Zogenix Inc.
Pharmaceutical & medical device company payment data from CMS Open Payments.
Total Payments
$3.7M
Doctors Paid
946
Transactions
2,534
2021 Total
$3.3M
Payment Breakdown by Category
Research$3.4M (90.1%)
Consulting$161,764 (4.3%)
Food & Beverage$34,980 (0.9%)
Travel$7,123 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $3.4M | 542 | 90.1% |
| Consulting Fee | $161,764 | 95 | 4.3% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $111,042 | 87 | 3.0% |
| Food and Beverage | $34,980 | 1,503 | 0.9% |
| Honoraria | $29,312 | 44 | 0.8% |
| Grant | $23,500 | 2 | 0.6% |
| Travel and Lodging | $7,123 | 25 | 0.2% |
| Education | $2,974 | 236 | 0.1% |
Payments by Type
Research
$3.4M
542 transactions
General
$370,694
1,992 transactions
Research Studies & Clinical Trials
| Study Name | Total Paid | Doctors | Records |
|---|---|---|---|
| MT-1621 | $1.1M | 0 | 351 |
| Zogenix ZX008-1900 (ZX1900) GPS (US) | $982,917 | 0 | 27 |
| LGS Efficacy & Safety | $865,777 | 0 | 75 |
| CDD (CDKL5 Deficiency Disorder) | $220,915 | 0 | 6 |
| A Study to Investigate the Efficacy and Safety of ZX008 (Fenfluramine Hydrochloride) as an Adjunctive Therapy in Children and Adults With Lennox-Gastaut Syndrome | $134,913 | 0 | 47 |
| An Open-Label Study of Continuation Treatment With Combination Pyrimidine Nucleosides in Patients With TK2 (Continuation) | $44,000 | 0 | 5 |
| ZX008 Expanded Access Protocol - Dravet Syndrome Treatment Plan | $37,785 | 2 | 19 |
| A Phase 1, Open-Label, Single-Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ZX008 (Fenfluramine Hydrochloride) in Subjects With Varying Degrees of Hepatic Impairment | $14,497 | 0 | 12 |
Payments by Medical Specialty
Top Paid Doctors
| Doctor | Specialty | Location | Total | 2021 |
|---|---|---|---|---|
| Michael Perry, Md, MD | Neurodevelopmental Disabilities | Fort Worth, TX | $29,181 | $0 |
| Dr. James Wheless, Md, MD | Neurology with Special Qualifications in Child Neurology | Memphis, TN | $26,960 | $0 |
| Dr. James Breitmeyer | Internal Medicine | San Diego, CA | $23,750 | $0 |
| Dr. O'neill D'cruz, Md, MD | Neurology | Chapel Hill, NC | $22,000 | $0 |
| Julio Flamini, M.d, M.D | Neurology | Atlanta, GA | $14,656 | $0 |
| Michael Chez, Md, MD | Neurology | Sacramento, CA | $12,692 | $0 |
| David Harrild, M.d, M.D | Pediatric Cardiology | Boston, MA | $11,925 | $0 |
| Mr. Gregory Holmes, M.d, M.D | Neurology | Burlington, VT | $11,250 | $0 |
| Steven Wolf, Md, MD | Neurology | New York, NY | $10,839 | $0 |
| Raman Sankar, M.d, M.D | Neurodevelopmental Disabilities | Los Angeles, CA | $9,783 | $0 |
| Mrs. Karen Keough, Md, MD | Neurology with Special Qualifications in Child Neurology | Austin, TX | $7,326 | $0 |
| Dr. Elizabeth Thiele, Md Phd, MD PHD | Neurology with Special Qualifications in Child Neurology | Boston, MA | $6,312 | $0 |
| Dr. Mary Zupanc, Md, MD | Neurology | Madison, WI | $6,300 | $0 |
| Dr. Sanjeev Kothare, Md, MD | Clinical Neurophysiology | New Hyde Park, NY | $5,900 | $0 |
| Ian Miller, Md, MD | Clinical Neurophysiology | Miami, FL | $5,600 | $0 |
| Dr. Steven Colan, Md, MD | Pediatrics | Boston, MA | $5,500 | $0 |
| Stephen Chan | Cardiovascular Disease | Pittsburgh, PA | $5,000 | $0 |
| Dr. Jeffrey Noebels, Md, MD | Research | Houston, TX | $5,000 | $0 |
| Joseph Sullivan, M.d, M.D | Neurology with Special Qualifications in Child Neurology | San Francisco, CA | $4,710 | $0 |
| Dr. Michio Hirano, M.d, M.D | Neurology | New York, NY | $4,500 | $0 |
| Dr. Douglas Smith, M.d, M.D | Sports Medicine | Roseville, MN | $4,113 | $0 |
| Kelly Knupp, Md, MD | Neurodevelopmental Disabilities | Aurora, CO | $4,050 | $0 |
| Shannon Blalock, Md, MD | Pediatric Cardiology | Dallas, TX | $3,600 | $0 |
| Dr. John Schreiber, Md, MD | Neurology with Special Qualifications in Child Neurology | Washington, DC | $3,510 | $0 |
| Jeffrey Dayton, Md, MD | Pediatric Cardiology | New York, NY | $3,488 | $0 |
Ad
Top Products
- Fintepla $1.2M
- ZX008 $134,913
Associated Products (4)
- ZX008 $134,913
- MT-1621 $44,000
- ZX008-1800 $37,785
- ZX008-1903 $14,497
Payment Categories
- Food & Beverage $34,980
- Consulting $161,764
- Travel & Lodging $7,123
- Research $3.4M
About Zogenix Inc.
Zogenix Inc. has made $3.7M in payments to 946 healthcare providers, recorded across 2,534 transactions in the CMS Open Payments database. In 2021, the company paid $3.3M. The top product by payment volume is Fintepla ($1.2M).
Payments were distributed across 59 medical specialties. The top specialty by payment amount is Neurology ($106,208 to 301 doctors).
Payment categories include: Food & Beverage ($34,980), Consulting ($161,764), Research ($3.4M), Travel & Lodging ($7,123).
Zogenix Inc. is associated with 4 products in the CMS Open Payments database, including ZX008, MT-1621, and ZX008-1800.